Follow us on:
Breaking News
February 2, 2026
Breaking News
Breaking News
Next Week at Contract Pharma
USP_Webinar_02-10-26_NextWeek@

Takeda Reshapes Leadership, Creates New Units Ahead of Fiscal 2026

 
Takeda Reshapes Leadership, Creates New Units Ahead of Fiscal 2026

The changes are designed to fuel speed, competitiveness and future growth.
Read More >>

gChem_eBook_1225_650x90
Headlines

Breaking News

Lilly to Build New Pennsylvania Manufacturing Facility

The site will be the company’s latest injectable medicine and device manufacturing facility.

SPONSOR

Speed & Flexibility: The New CDMO Advantage

Pharma’s future demands faster, more agile partners. See how leading CDMOs like ROIS are adapting to shifting market and regulatory needs.

Breaking News

Frontage Labs Expands Early Phase Clinical Capabilities

Phase I clinical unit in Secaucus to conduct large scale Phase I and Bioequivalence studies and radiolabeled human AME research.

Breaking News
Promotions & Moves

Quotient Therapeutics Appoints Susan Keefe as CFO

Keefe has 30 years of experience in finance, accounting and operations in the life sciences.

SPONSOR

Beyond Protection: Evolving Trends In Secondary Packaging

Drawing insights from industry leaders and results from an in-depth Contract Pharma reader survey, this eBook provides a timely snapshot of what matters most to today’s packaging decision-makers.

AAPS_eNL_0226_650x250

Breaking News
Promotions & Moves

Alterome Therapeutics Appoints Leonardo Faoro as New CMO

Faoro most recently served in the same chief medical officer capacity at Quanta Therapeutics.

SPONSOR

Overcoming Tablet Lubrication Hurdles in Modern Formulation

Get expert insight and data-driven strategies to solve common lubrication issues—whether launching a new product or updating an existing one.

Featured Resources

Solution Content Centers SPOTLIGHT

Eagle Analytical

Eagle is an FDA- and DEA-registered, A2LA ISO 17025-accredited CGMP laboratory providing analytical, microbiological, consulting, and technical services. From our 80,000+ sq. ft. state-of-the-art facility, we support compliance and quality assurance needs from raw materials to finished products.

 

Solution Content Centers SPOTLIGHT

IDT Biologika

IDT Biologika is a global CDMO for vaccines, recombinant proteins, viral vectors, gene & immune therapeutics, monoclonal antibodies, oncolytic viruses and other sterile injectables. End-to-end services in process development, drug substance manufacturing, fill&finish, packaging, quality control and analytics.